The Randle cycle revisited: a new head for an old hat.

In 1963, Lancet published a paper by Randle et al. that proposed a "glucose-fatty acid cycle" to describe fuel flux between and fuel selection by tissues. The original biochemical mechanism explained the inhibition of glucose oxidation by fatty acids. Since then, the principle has been confirmed by many investigators. At the same time, many new mechanisms controlling the utilization of glucose and fatty acids have been discovered. Here, we review the known short- and long-term mechanisms involved in the control of glucose and fatty acid utilization at the cytoplasmic and mitochondrial level in mammalian muscle and liver under normal and pathophysiological conditions. They include allosteric control, reversible phosphorylation, and the expression of key enzymes. However, the complexity is formidable. We suggest that not all chapters of the Randle cycle have been written.

[1]  N. Ruderman,et al.  AMPK and the biochemistry of exercise: implications for human health and disease. , 2009, The Biochemical journal.

[2]  J. Enríquez,et al.  Respiratory active mitochondrial supercomplexes. , 2008, Molecular cell.

[3]  C. Kahn,et al.  Endogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle. , 2008, Endocrinology.

[4]  M. Rigoulet,et al.  Mitochondrial Oxidative Phosphorylation Is Regulated by Fructose 1,6-Bisphosphate , 2008, Journal of Biological Chemistry.

[5]  G. Shulman,et al.  Muscle-Specific IRS-1 Ser→Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle , 2008, Diabetes.

[6]  Ashish Gangasani,et al.  Tissue-specific pyruvate dehydrogenase complex deficiency causes cardiac hypertrophy and sudden death of weaned male mice. , 2008, American journal of physiology. Heart and circulatory physiology.

[7]  J. Hoek,et al.  Regulation of hexokinase binding to VDAC , 2008, Journal of bioenergetics and biomembranes.

[8]  C. R. Wilson,et al.  Adaptation and Maladaptation of the Heart in Obesity , 2008, Hypertension.

[9]  R. Schwenk,et al.  Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. , 2008, Cardiovascular research.

[10]  Robert A. Harris,et al.  Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. , 2008, American journal of physiology. Endocrinology and metabolism.

[11]  Peter Tontonoz,et al.  Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.

[12]  K. Sakamoto,et al.  Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. , 2008, American journal of physiology. Endocrinology and metabolism.

[13]  David Goff,et al.  Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. , 2008, Hypertension.

[14]  Michael E. Lassman,et al.  Malonyl CoenzymeA Decarboxylase Regulates Lipid and Glucose Metabolism in Human Skeletal Muscle , 2008, Diabetes.

[15]  V. Zammit Carnitine palmitoyltransferase 1: Central to cell function , 2008, IUBMB life.

[16]  J. Girard,et al.  Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. , 2008, The Journal of clinical investigation.

[17]  M. Laakso,et al.  Downregulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance , 2008, Cell.

[18]  Robert A. Harris,et al.  Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.

[19]  B. Morio,et al.  Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. , 2008, The Journal of clinical investigation.

[20]  Xianlin Han,et al.  Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart , 2007 .

[21]  Robert V Farese,et al.  Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle. , 2007, American journal of physiology. Endocrinology and metabolism.

[22]  P. Razeghi,et al.  Proposed Regulation of Gene Expression by Glucose in Rodent Heart , 2007, Gene regulation and systems biology.

[23]  S. Wakil,et al.  Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity , 2007, Proceedings of the National Academy of Sciences.

[24]  D. Hardie,et al.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.

[25]  C. R. Wilson,et al.  Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats. , 2007, The Biochemical journal.

[26]  M. Watford,et al.  Leucing weight with a futile cycle. , 2007, Cell metabolism.

[27]  X. Leverve Mitochondrial function and substrate availability , 2007, Critical care medicine.

[28]  M. Rider,et al.  The AMP-activated protein kinase: more than an energy sensor. , 2007, Essays in biochemistry.

[29]  J. Girard,et al.  ChREBP, a transcriptional regulator of glucose and lipid metabolism. , 2007, Annual review of nutrition.

[30]  J. Pessin,et al.  Ins (endocytosis) and outs (exocytosis) of GLUT4 trafficking. , 2007, Current opinion in cell biology.

[31]  J. Auwerx,et al.  PPARγ in human and mouse physiology , 2007 .

[32]  Robert V Farese,et al.  Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. , 2007, Cell metabolism.

[33]  S. Kersten,et al.  PPARα and dyslipidemia , 2007 .

[34]  R. Zivadinov Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? , 2007, Neurology.

[35]  Jimmy D Bell,et al.  The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance , 2007, Nuclear receptor.

[36]  R. Marchase,et al.  Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation. , 2007, American journal of physiology. Heart and circulatory physiology.

[37]  M. Sugden In appreciation of Sir Philip Randle: the glucose-fatty acid cycle. , 2007, The British journal of nutrition.

[38]  Xianlin Han,et al.  CD36 Deficiency Rescues Lipotoxic Cardiomyopathy , 2007, Circulation research.

[39]  S. Wakil,et al.  Reduced Heart Size and Increased Myocardial Fuel Substrate Oxidation in ACC2 Mutant Mice , 2007, American journal of physiology. Heart and circulatory physiology.

[40]  D. Carling,et al.  Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. , 2007, The Biochemical journal.

[41]  K. Petersen,et al.  Disordered lipid metabolism and the pathogenesis of insulin resistance. , 2007, Physiological reviews.

[42]  F. Foufelle,et al.  SREBP-1c Transcription Factor and Lipid Homeostasis: Clinical Perspective , 2007, Hormone Research in Paediatrics.

[43]  D. Kelly,et al.  Insulin-Resistant Heart Exhibits a Mitochondrial Biogenic Response Driven by the Peroxisome Proliferator-Activated Receptor-&agr;/PGC-1&agr; Gene Regulatory Pathway , 2007, Circulation.

[44]  D. Hardie,et al.  AMP-activated protein kinase as a drug target. , 2007, Annual review of pharmacology and toxicology.

[45]  K. Petersen,et al.  Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction , 2006, Diabetes.

[46]  P. Arner,et al.  Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. , 2006, Essays in biochemistry.

[47]  K. Jishage,et al.  Absence of Malonyl Coenzyme A Decarboxylase in Mice Increases Cardiac Glucose Oxidation and Protects the Heart From Ischemic Injury , 2006, Circulation.

[48]  E. Disse,et al.  Short-term activation of peroxysome proliferator-activated receptor β/δ increases fatty acid oxidation but does not restore insulin action in muscle cells from type 2 diabetic patients , 2006, Journal of Molecular Medicine.

[49]  J. Repa,et al.  Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. , 2006, Cell metabolism.

[50]  B. Viollet,et al.  Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. , 2006, American journal of physiology. Heart and circulatory physiology.

[51]  G. Lopaschuk,et al.  AMPK alterations in cardiac physiology and pathology: enemy or ally? , 2006, The Journal of physiology.

[52]  B. Viollet,et al.  AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits , 2006, Diabetes.

[53]  C. Newgard,et al.  Obesity-related derangements in metabolic regulation. , 2006, Annual review of biochemistry.

[54]  Ziwei Gu,et al.  Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Rigoulet,et al.  The ROS Production Induced by a Reverse-Electron Flux at Respiratory-Chain Complex 1 is Hampered by Metformin , 2006, Journal of bioenergetics and biomembranes.

[56]  W. Wahli,et al.  Transcriptional regulation of metabolism. , 2006, Physiological reviews.

[57]  Alexander G. Gray,et al.  Regulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: role of serine 24 phosphorylation. , 2006, Molecular endocrinology.

[58]  B. Finck Effects of PPARα on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle? , 2006, Expert review of cardiovascular therapy.

[59]  E. Disse,et al.  Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells , 2006, Diabetologia.

[60]  M. Holness,et al.  Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases , 2006, Archives of physiology and biochemistry.

[61]  J. Hanover,et al.  The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code" , 2005, Science's STKE.

[62]  Ping Li,et al.  Peroxisome Proliferator-activated Receptor-γ Co-activator 1α-mediated Metabolic Remodeling of Skeletal Myocytes Mimics Exercise Training and Reverses Lipid-induced Mitochondrial Inefficiency* , 2005, Journal of Biological Chemistry.

[63]  Ziwei Gu,et al.  Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[64]  C. R. Wilson,et al.  Metabolic Energetics and Genetics in the Heart , 2005, Annals of the New York Academy of Sciences.

[65]  B. Viollet,et al.  Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. , 2005, Diabetes.

[66]  J. Girard,et al.  Demonstration of N- and C-terminal domain intramolecular interactions in rat liver carnitine palmitoyltransferase 1 that determine its degree of malonyl-CoA sensitivity. , 2005, The Biochemical journal.

[67]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[68]  S. Chirala,et al.  Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[69]  J. Holloszy,et al.  A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes. , 2005, Cell metabolism.

[70]  É. Hajduch,et al.  Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. , 2004, The Biochemical journal.

[71]  D. Vertommen,et al.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. , 2004, The Biochemical journal.

[72]  David Carling,et al.  Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids. , 2004, European journal of biochemistry.

[73]  M. Chandler,et al.  Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation , 2004, Circulation research.

[74]  L. Golfman,et al.  Linking Gene Expression to Function: Metabolic Flexibility in the Normal and Diseased Heart , 2004, Annals of the New York Academy of Sciences.

[75]  David Millington,et al.  Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.

[76]  D. Carling,et al.  Bypassing the glucose/fatty acid cycle: AMP-activated protein kinase. , 2003, Biochemical Society transactions.

[77]  M. Holness,et al.  Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. , 2003, Biochemical Society transactions.

[78]  K. Frayn The glucose-fatty acid cycle: a physiological perspective. , 2003, Biochemical Society transactions.

[79]  X. Leverve,et al.  Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. , 2003, Diabetes & metabolism.

[80]  S. Wakil,et al.  Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[81]  N. Ruderman,et al.  Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase. , 2003, Diabetes.

[82]  Y. Le Marchand-Brustel,et al.  Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. , 2003, Diabetes.

[83]  M. Holness,et al.  Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. , 2003, American journal of physiology. Endocrinology and metabolism.

[84]  H. Taegtmeyer Switching Metabolic Genes to Build a Better Heart , 2002, Circulation.

[85]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[86]  J. Tavaré,et al.  The Identification of ATP-citrate Lyase as a Protein Kinase B (Akt) Substrate in Primary Adipocytes* , 2002, The Journal of Biological Chemistry.

[87]  M. Prentki,et al.  Coordinate Regulation of Malonyl-CoA Decarboxylase,sn-Glycerol-3-phosphate Acyltransferase, and Acetyl-CoA Carboxylase by AMP-activated Protein Kinase in Rat Tissues in Response to Exercise* , 2002, The Journal of Biological Chemistry.

[88]  F. Foufelle,et al.  New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. , 2002, The Biochemical journal.

[89]  J. Dyck,et al.  Phosphorylation of cardiac protein kinase B is regulated by palmitate. , 2002, American journal of physiology. Heart and circulatory physiology.

[90]  P. Razeghi,et al.  Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. , 2002, Diabetes.

[91]  S. Eaton Control of mitochondrial beta-oxidation flux. , 2002, Progress in lipid research.

[92]  D. Severson,et al.  A Role for Peroxisome Proliferator-activated Receptor α (PPARα) in the Control of Cardiac Malonyl-CoA Levels , 2002, The Journal of Biological Chemistry.

[93]  R. Evans,et al.  Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[94]  O. Frazier,et al.  Metabolic Gene Expression in Fetal and Failing Human Heart , 2001, Circulation.

[95]  B. Kemp,et al.  Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line. , 2001, Archives of biochemistry and biophysics.

[96]  H. Taegtmeyer,et al.  Reactivation of Peroxisome Proliferator-activated Receptor α Is Associated with Contractile Dysfunction in Hypertrophied Rat Heart* , 2001, The Journal of Biological Chemistry.

[97]  M. Rigoulet,et al.  The mitochondrial consequences of uncoupling intact cells depend on the nature of the exogenous substrate. , 2001, The Biochemical journal.

[98]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[99]  C. R. Wilson,et al.  Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids. , 2001, American journal of physiology. Endocrinology and metabolism.

[100]  G. Shipley,et al.  Uncoupling protein 3 transcription is regulated by peroxisome proliferator‐activated receptor α in the adult rodent heart , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[101]  D. Carling,et al.  Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia , 2000, Current Biology.

[102]  H. Taegtmeyer,et al.  Improved energy homeostasis of the heart in the metabolic state of exercise. , 2000, American journal of physiology. Heart and circulatory physiology.

[103]  M. Prentki,et al.  Activation of Malonyl-CoA Decarboxylase in Rat Skeletal Muscle by Contraction and the AMP-activated Protein Kinase Activator 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside* , 2000, The Journal of Biological Chemistry.

[104]  J. Ward,et al.  Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ) , 2000, Molecular and Cellular Biology.

[105]  L. Mandarino,et al.  Fuel selection in human skeletal muscle in insulin resistance: a reexamination. , 2000, Diabetes.

[106]  M. Gibala,et al.  Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle. , 2000, Acta physiologica Scandinavica.

[107]  R. Harris,et al.  Fibre-type specific modification of the activity and regulation of skeletal muscle pyruvate dehydrogenase kinase (PDK) by prolonged starvation and refeeding is associated with targeted regulation of PDK isoenzyme 4 expression. , 2000, The Biochemical journal.

[108]  S. Chirala,et al.  The subcellular localization of acetyl-CoA carboxylase 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[109]  S. Doronin,et al.  Phosphorylation of recombinant human ATP:citrate lyase by cAMP-dependent protein kinase abolishes homotropic allosteric regulation of the enzyme by citrate and increases the enzyme activity. Allosteric activation of ATP:citrate lyase by phosphorylated sugars. , 2000, Biochemistry.

[110]  Rena R Wing,et al.  Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. , 1999, American journal of physiology. Endocrinology and metabolism.

[111]  V. Zammit The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function. , 1999, The Biochemical journal.

[112]  H. Taegtmeyer,et al.  Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. , 1999, American journal of physiology. Endocrinology and metabolism.

[113]  G. Shulman,et al.  Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. , 1999, The American journal of physiology.

[114]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[115]  W. Wahli,et al.  Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .

[116]  D. Hardie,et al.  Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase. , 1999, European journal of biochemistry.

[117]  D L Rothman,et al.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.

[118]  P. J. Randle,et al.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. , 1998, Diabetes/metabolism reviews.

[119]  M. Rider,et al.  Mechanisms of control of heart glycolysis. , 1998, European journal of biochemistry.

[120]  Margaret S. Wu,et al.  Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression. , 1998, Endocrinology.

[121]  H. Taegtmeyer,et al.  Regulation of Energy Metabolism of the Heart during Acute Increase in Heart Work* , 1998, The Journal of Biological Chemistry.

[122]  M. Rigoulet,et al.  Oxidative phosphorylation in intact hepatocytes: Quantitative characterization of the mechanisms of change in efficiency and cellular consequences , 1998, Molecular and Cellular Biochemistry.

[123]  Eric Fontaine,et al.  Quantitative analysis of some mechanisms affecting the yield of oxidative phosphorylation: Dependence upon both fluxes and forces , 1998, Molecular and Cellular Biochemistry.

[124]  J. McGarry,et al.  Glucose-fatty acid interactions in health and disease. , 1998, The American journal of clinical nutrition.

[125]  L. Hue,et al.  Cyclic AMP suppresses the inhibition of glycolysis by alternative oxidizable substrates in the heart. , 1998, The Journal of clinical investigation.

[126]  D. Hardie,et al.  AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, American journal of physiology. Endocrinology and metabolism.

[127]  C. Rosiers,et al.  A 13C Mass Isotopomer Study of Anaplerotic Pyruvate Carboxylation in Perfused Rat Hearts* , 1997, The Journal of Biological Chemistry.

[128]  E. Coyle,et al.  Fatty acid oxidation is directly regulated by carbohydrate metabolism during exercise. , 1997, The American journal of physiology.

[129]  B. Kemp,et al.  Contraction-induced Changes in Acetyl-CoA Carboxylase and 5′-AMP-activated Kinase in Skeletal Muscle* , 1997, The Journal of Biological Chemistry.

[130]  F. V. van Nieuwenhoven,et al.  Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: involvement of sarcolemmal proteins. , 1997, Journal of lipid research.

[131]  M. Palacín,et al.  Insulin-induced Recruitment of Glucose Transporter 4 (GLUT4) and GLUT1 in Isolated Rat Cardiac Myocytes , 1997, The Journal of Biological Chemistry.

[132]  D. Hardie,et al.  Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. , 1997, The American journal of physiology.

[133]  M. Sugden,et al.  Pyruvate inhibition of pyruvate dehydrogenase kinase , 1996, FEBS letters.

[134]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[135]  L. Witters,et al.  Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. , 1996, Biochimica et biophysica acta.

[136]  J Auwerx,et al.  Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. , 1996, Journal of lipid research.

[137]  S. Pentyala,et al.  Effect of oxaloacetate and phosphorylation on ATP-citrate lyase activity. , 1995, Biochemistry.

[138]  G. Lopaschuk,et al.  Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. , 1994, The American journal of physiology.

[139]  M. Brand,et al.  The causes and functions of mitochondrial proton leak. , 1994, Biochimica et biophysica acta.

[140]  E. Van Schaftingen,et al.  Short‐term control of glucokinase activity: role of a regulatory protein , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[141]  J. E. Lawson,et al.  Molecular cloning and expression of the catalytic subunit of bovine pyruvate dehydrogenase phosphatase and sequence similarity with protein phosphatase 2C. , 1993, Biochemistry.

[142]  M. Rider,et al.  Role of fructose 2,6-bisphosphate in the control of heart glycolysis. , 1993, The Journal of biological chemistry.

[143]  M. Birnbaum,et al.  Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. , 1993, The Journal of biological chemistry.

[144]  M. Berry,et al.  Effects of fatty acid oxidation on glucose utilization by isolated hepatocytes , 1993, FEBS letters.

[145]  J. McGarry,et al.  What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.

[146]  R. Palfreyman,et al.  Kinetic resolution of the separate GLUT1 and GLUT4 glucose transport activities in 3T3-L1 cells. , 1992, The Biochemical journal.

[147]  R. Shulman,et al.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[148]  Christine Dreyer,et al.  Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.

[149]  H. Taegtmeyer,et al.  Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. , 1991, The American journal of physiology.

[150]  E. Van Schaftingen,et al.  Competitive inhibition of liver glucokinase by its regulatory protein. , 1991, European journal of biochemistry.

[151]  J. Eckel,et al.  Induction of insulin resistance in primary cultured adult cardiac myocytes. , 1991, Endocrinology.

[152]  C. Nobes,et al.  The mechanism of stimulation of respiration by fatty acids in isolated hepatocytes. , 1990, The Journal of biological chemistry.

[153]  C. Nobes,et al.  Non-ohmic proton conductance of the mitochondrial inner membrane in hepatocytes. , 1990, The Journal of biological chemistry.

[154]  M. Brand The proton leak across the mitochondrial inner membrane. , 1990, Biochimica et biophysica acta.

[155]  J. Duszyński,et al.  Regulation of mitochondrial resting state respiration: slip, leak, heterogeneity? , 1990, Biochimica et biophysica acta.

[156]  J. Mccormack,et al.  Role of calcium ions in regulation of mammalian intramitochondrial metabolism. , 1990, Physiological reviews.

[157]  H. O. Spivey,et al.  Substrate channeling of NADH and binding of dehydrogenases to complex I. , 1989, The Journal of biological chemistry.

[158]  A. L. Kerbey,et al.  Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. , 1988, Diabetes/metabolism reviews.

[159]  A. Sherry,et al.  Evaluation of carbon flux and substrate selection through alternate pathways involving the citric acid cycle of the heart by 13C NMR spectroscopy. , 1988, The Journal of biological chemistry.

[160]  M. Rider,et al.  Palmitate inhibits liver glycolysis. Involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle. , 1988, The Biochemical journal.

[161]  M. Rider,et al.  Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. , 1987, The Biochemical journal.

[162]  J. Mccormack,et al.  Role of Ca2+ ions in the regulation of intramitochondrial metabolism in rat heart. Evidence from studies with isolated mitochondria that adrenaline activates the pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes by increasing the intramitochondrial concentration of Ca2+. , 1984, The Biochemical journal.

[163]  Jack E. Baldwin,et al.  The evolution of metabolic cycles , 1981, Nature.

[164]  J C Stanley,et al.  The glucose-fatty acid cycle. Relationship between glucose utilization in muscle, fatty acid oxidation in muscle and lipolysis in adipose tissue. , 1981, British journal of anaesthesia.

[165]  G. Brooks,et al.  Glycogen repletion following continuous and intermittent exercise to exhaustion. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[166]  H A Krebs,et al.  Utilization of energy-providing substrates in the isolated working rat heart. , 1980, The Biochemical journal.

[167]  J. McGarry,et al.  A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. , 1977, The Journal of clinical investigation.

[168]  S. Cheema-Dhadli,et al.  Properties of the citrate transporter in rat heart: implications for regulation of glycolysis by cytosolic citrate. , 1976, Canadian journal of biochemistry.

[169]  C. Hales,et al.  The inhibition of rat liver glucokinase by palmitoyl-CoA. , 1969, Biochimica et biophysica acta.

[170]  E. Newsholme,et al.  Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. , 1964, The Biochemical journal.

[171]  J. Williamson METABOLIC EFFECTS OF EPINEPHRINE IN THE ISOLATED, PERFUSED RAT HEART. I. DISSOCIATION OF THE GLYCOGENOLYTIC FROM THE METABOLIC STIMULATORY EFFECT. , 1964, The Journal of biological chemistry.

[172]  E. Newsholme,et al.  Citrate as an Intermediary in the Inhibition of Phosphofructokinase in Rat Heart Muscle by Fatty Acids, Ketone Bodies, Pyruvate, Diabetes and Starvation , 1963, Nature.

[173]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[174]  E. C. Slater,et al.  Uncoupling activity of long-chain fatty acids. , 1962, Biochimica et biophysica acta.

[175]  E. Newsholme,et al.  Effect of Fatty Acids, Ketone Bodies, Diabetes and Starvation on Pyruvate Metabolism in Rat Heart and Diaphragm Muscle , 1962, Nature.

[176]  J. Williamson Effects of insulin and diet on the metabolism of L-lactate and glucose by the perfused rat heart. , 1962, The Biochemical journal.

[177]  E. Newsholme,et al.  Inhibition of the Phosphofructokinase Reaction in Perfused Rat Heart by Respiration of Ketone Bodies, Fatty Acids and Pyruvate , 1962, Nature.

[178]  Louise Lantier,et al.  AMPK: Lessons from transgenic and knockout animals. , 2009, Frontiers in bioscience.

[179]  O. Ilkayeva,et al.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.

[180]  J. Friedman,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2008 .

[181]  J. Auwerx,et al.  PPARgamma in human and mouse physiology. , 2007, Biochimica et biophysica acta.

[182]  A. Bonen,et al.  Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins , 2007, Lipids.

[183]  Xianlin Han,et al.  Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. , 2007, The Journal of clinical investigation.

[184]  M. Rigoulet,et al.  Mechanisms of mitochondrial response to variations in energy demand in eukaryotic cells. , 2007, American journal of physiology. Cell physiology.

[185]  A. Warley,et al.  A reevaluation of the roles of hexokinase I and II in the heart. , 2007, American journal of physiology. Heart and circulatory physiology.

[186]  S. Kersten,et al.  PPARalpha and dyslipidemia. , 2007, Biochimica et biophysica acta.

[187]  A. Means,et al.  Chutes and Ladders: the search for protein kinases that act on AMPK. , 2006, Trends in biochemical sciences.

[188]  D. Carling,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[189]  P. Byphili,et al.  Metabolic fuel selection: general integration at the whole-body level , 2005 .

[190]  B. Viollet,et al.  The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. , 2003, The Journal of clinical investigation.

[191]  J. McGarry Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.

[192]  B. Goodpaster,et al.  Muscle triglyceride and insulin resistance. , 2002, Annual review of nutrition.

[193]  Xianlin Han,et al.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.

[194]  J. Olefsky,et al.  Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[195]  S. Specific Inhibition of Glucokinase by Long Chain Acyl Coenzymes A below the Critical Micelle Concentration * , 2001 .

[196]  B. Ames,et al.  Part X • Chapter 27 – Oxidants and aging , 2000 .

[197]  W. Wahli,et al.  Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. , 1999, The Journal of clinical investigation.

[198]  K. M. Popov,et al.  Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. , 1998, The Biochemical journal.

[199]  M. Carlson,et al.  The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.

[200]  D. Moller,et al.  Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. , 1998, Endocrinology.

[201]  A. Mahfoudi,et al.  Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR) , 1993, Biology of the cell.

[202]  L. Hue,et al.  Role of fructose 2,6-bisphosphate in the control of glycolysis. Stimulation of glycogen synthesis by lactate in the isolated working rat heart. , 1993, Acta cardiologica.

[203]  H. O. Spivey,et al.  Substrate channeling of NADH in mitochondrial redox processes. , 1992, Current topics in cellular regulation.

[204]  H. Keller,et al.  Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. , 1992, Cell.

[205]  A. Schoolwerth,et al.  Metabolite transport in mitochondria. , 1979, Annual review of biochemistry.

[206]  P. J. Randle,et al.  Regulation of Glucose Uptake by Muscle , 1962 .

[207]  P. Iynedjian Cellular and Molecular Life Sciences Review Molecular Physiology of Mammalian Glucokinase , 2022 .